poisar

Stock

ResMed Inc. RMD

$231.49+1.22%

Overview

RMD market data

Price History

RMD price chart · 1M
O
229.96
H
234.02
L
229.27
C
231.49
Vol
49,413.00
Source
US equities market feed
Observed
Aug 21, 2026, 12:00 AM
Cadence
Five-minute page cache; daily and stored hourly bars
Status
fresh

Key Stats & Performance

Open
$229.96
Previous Close
$228.70
Day High
$234.02
Day Low
$229.27
52 Week High
$259.45
52 Week Low
$180.06
7 Day Return
+3.48%
30 Day Return
+20.20%
90 Day Return
+11.61%
1 Year Return
-10.11%
Daily Notional Volume
$11.4M
Latest daily bar volume multiplied by its closing price.

Valuation & Profitability

Provider-backed
P/E (TTM)
21.47
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
$10.43
Diluted earnings per share over the trailing twelve months.
Beta
0.74
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
1.2%
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
26.9%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$180.27 – $293.81
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $32.7B · P/B 4.29 · P/S 5.79.

Company News

10 captured
ResMed shares are trading higher after Rothschild & Co. initiated coverage on the stock with a Neutral rating and announced a $230 price target.Benzinga · Aug 19, 2026, 5:45 PM
Rothschild & Co Initiates Coverage On ResMed with Neutral Rating, Announces Price Target of $230Benzinga · Aug 19, 2026, 2:47 PM
RBC Capital Maintains Sector Perform on ResMed, Raises Price Target to $244Benzinga · Aug 7, 2026, 8:11 PM
ResMed shares are trading lower after multiple analyst firms lowered their respective price targets on the stock.Benzinga · Aug 7, 2026, 6:18 PM
JS&P 500 Hits Record As Jobs Shock Sinks Rate-Hike Bets: Stock Market TodayBenzinga · Aug 7, 2026, 5:27 PM
Piper Sandler Maintains Neutral on ResMed, Lowers Price Target to $225Benzinga · Aug 7, 2026, 5:08 PM
Keybanc Maintains Overweight on ResMed, Lowers Price Target to $255Benzinga · Aug 7, 2026, 2:13 PM
Wells Fargo Maintains Equal-Weight on ResMed, Lowers Price Target to $215Benzinga · Aug 7, 2026, 2:11 PM
Trade Desk Posts Downbeat Q2 Results, Joins Sezzle, Resmed, Ouster And Other Big Stocks Moving Lower In Friday’s Pre-Market SessionBenzinga · Aug 7, 2026, 12:02 PM
Resmed Raises Quarterly Dividend From $0.60 To $0.66/ShareBenzinga · Aug 6, 2026, 8:47 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock